Methylene chloride in paints linked to high fatality rates: JAMA

Written By :  Dr Satabdi Saha
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2021-04-26 00:17 GMT   |   Update On 2021-04-26 00:17 GMT

Results of a recent case series has demonstrated that despite regulations to address the toxic effects of methylene chloride use for consumers and workers, there are continuing fatalities in the US, particularly in occupational settings. The findings have been put forth in JAMA Internal Medicine. "Prevention of fatalities associated with methylene chloride exposure should...

Login or Register to read the full article

Results of a recent case series has demonstrated that despite regulations to address the toxic effects of methylene chloride use for consumers and workers, there are continuing fatalities in the US, particularly in occupational settings. The findings have been put forth in JAMA Internal Medicine.

"Prevention of fatalities associated with methylene chloride exposure should emphasize the use of safer substitutes, rather than hazard warnings or reliance on personal protective equipment."the research team opined.

Methylene chloride is a halogenated organic solvent widely used in paint strippers, cleaners, adhesives, and sealants. Despite label warnings and occupational standards, methylene chloride–related fatalities continue to occur in the United States.The most serious acute effect of methylene chloride is narcosis, ranging from light-headedness, nausea, and headache to respiratory depression and death. Methylene chloride can also sensitize the myocardium to arrhythmias, a particular risk for people with cardiovascular disease. Other acute effects include skin burns from contact, corneal damage due to ocular splashes, and indirect consequences of narcosis (eg, falls or other trauma).

The study was carried out to identify and analyze methylene chloride–related fatalities in the US. For this case series, we conducted systematic searches of sources, including PubMed and government databases, for unintentional fatalities in the US that were associated with exposure to methylene chloride or products containing methylene chloride between 1980 and 2018. Researchers reviewed all available information, including inspection reports, autopsy reports, and medical records; data analyses were conducted from August 2018 to August 2020. Cases were categorized as those occurring in the home (consumer deaths) or at work (occupational deaths).

The primary outcomw was to determine characteristics of the methylene chloride–related fatalities, we recorded demographic information; the setting; circumstances, including information on safety measures used, if available; and products used.

Results revealed some key facts.

  • From 1980 to 2018, 85 methylene chloride–related fatalities were identified in the US, including 74 (87%) in occupational settings; of those who died, 75 (94%) were men, and for the 70 cases with available information, the median (interquartile range) age of the decedents was 31 (24-46) years.
  • Paint strippers were the most common products involved in methylene chloride–related fatalities (n = 60).
  • The proportion of occupational fatalities related to paint stripping increased from 22 (55%) before 2000 to 30 (88%) after 2000.
  • Similarly, occupational fatalities associated with bathtub or paint stripping in bathrooms increased from 2 (5%) before 2000 to 21 (62%) after 2000.
  • From 1985 to 2017, the American Association of Poison Control Centers documented 37 201 nonfatal methylene chloride cases, with a decrease in the annual number of cases starting in the late 1990s.

For the full article follow the link: doi:10.1001/jamainternmed.2021.1063

Primary source: JAMA Internal Medicine


Tags:    
Article Source : JAMA Internal Medicine

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News